Stalevo
In brief
- Although Stalevo is prescription‑only in major regulated markets, in our pharmacy you can buy stalevo without a prescription, with delivery across Australia and discreet packaging.
- Stalevo is used to treat Parkinson’s disease in adults experiencing motor fluctuations (“wearing off”); it combines levodopa (a dopamine precursor), carbidopa (a dopa‑decarboxylase inhibitor that increases central levodopa availability) and entacapone (a COMT inhibitor that prolongs levodopa’s effect).
- The usual dose is matched to the patient’s existing levodopa/DDCI regimen; commonly one Stalevo tablet per dose taken 3–7 times daily as required. Available strengths correspond to levodopa 50, 75, 100, 125, 150 and 200 mg (each tablet also contains the appropriate carbidopa amount and 200 mg entacapone). Do not exceed 200 mg levodopa per dose or about 2,000 mg levodopa per day unless advised by a specialist.
- Form of administration: oral film‑coated tablets (blister packs).
- Onset time: typically begins to work within about 20–60 minutes after oral dosing, though individual response varies.
- Duration of action: variable by patient and dose—immediate levodopa effects commonly last around 3–6 hours per dose; entacapone generally prolongs “on” time by approximately 1–2 hours.
- Alcohol warning: avoid or limit alcohol, as it can worsen side effects such as dizziness, orthostatic hypotension and confusion.
- The most common side effect is nausea; other frequent effects include dyskinesia (involuntary movements), urine discolouration, dizziness/orthostatic hypotension and insomnia.
- Would you like to try stalevo without a prescription?
Basic Stalevo Information
- INN (International Nonproprietary Name): Levodopa, Carbidopa, Entacapone.
- Brand Names Available In Australia: Stalevo (brown, oval film-coated tablets), supplied in blister packs; Rx-only boxed packaging.
- ATC Code: N04BA03 (Levodopa combinations).
- Forms & Dosages: Stalevo film-coated tablets; all strengths contain 200 mg entacapone.
- Manufacturers In Australia: Novartis / Orion (distributed by national subsidiaries).
- Registration Status In Australia: Approved by national regulatory agency for prescription-only use.
- OTC / Rx Classification: Prescription Only Medicine (Rx).
Critical Warnings & Restrictions
Are there people who must not get Stalevo or need special checks first?
Stalevo is a prescription-only medicine and must be assessed before supply.
Absolute contraindications include known hypersensitivity to levodopa, carbidopa or entacapone.
Do not use Stalevo in patients with severe liver disease.
Avoid Stalevo if pheochromocytoma is present because of hypertensive crisis risk.
Narrow-angle glaucoma is a contraindication and should be excluded before starting therapy.
High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)
Pregnancy and breastfeeding require a careful risk–benefit discussion with the prescriber before starting Stalevo.
Stalevo is not indicated for patients under 18 years; safety in children is unestablished.
Severe hepatic impairment increases entacapone exposure, so avoid or reduce dose in hepatic disease.
Patients with a history of psychosis need specialist review before initiating Stalevo due to dopaminergic effects.
People with significant cardiovascular disease should have baseline assessment and monitoring.
For frail or elderly patients, consider lower starting doses and close follow-up for hypotension, confusion and dyskinesia.
Before supply, recommend a medication review and baseline vital checks including blood pressure and heart rate.
Consider an ECG if there is a relevant cardiac history or arrhythmia risk.
Baseline checks of mental health status, liver function and renal function are advised in frail or medically complex patients.
- Dispensing checklist: pregnancy/breastfeeding status.
- Dispensing checklist: current psychotropic medications including antipsychotics and MAOI use.
- Dispensing checklist: history of dyskinesia or impulse control disorders.
- Dispensing checklist: orthostatic symptoms or frequent falls.
Urgent review is needed for any of the following symptoms:
- Severe confusion or new-onset hallucinations.
- Sudden onset of sleep or lapses of consciousness.
- Very low blood pressure or fainting episodes.
- Severe or sustained dyskinesia (involuntary movements).
Interaction With Activities (Driving, Workplace Safety Under Australian Law)
Does Stalevo affect driving or work tasks that need alertness?
Stalevo can cause dizziness, somnolence and impaired judgement in some patients.
Do not drive or operate heavy machinery until you know how Stalevo affects you.
If you experience dizziness, sudden sleepiness, blurred vision or altered concentration, do not drive and notify your prescriber.
For those in safety-sensitive roles, workplace risk assessments should be performed before returning to full duties.
Workplace safety checklist for safety-sensitive roles:
- Confirm stable symptom control and medication timing.
- Assess daytime sleepiness and record any sleep attacks.
- Check orthostatic blood pressure and fall risk.
- Document that the treating clinician has approved workplace duties.
Q&A — “Can I Drive After Taking It In Australia?”
Short answer: Not until you know how Stalevo affects you.
Stalevo may cause dizziness, sudden sleepiness and blurred vision in some people.
Do not drive, ride a motorcycle or operate heavy machinery until you have established how the medicine affects alertness and coordination.
If you notice sudden sleep onset, extreme drowsiness or any visual disturbance after taking Stalevo, stop driving immediately and seek medical advice.
Notify your prescriber if these symptoms occur so dosing or medication choices can be reviewed.
For legal and insurance reasons, follow Australian road and workplace safety guidance and do not drive if unfit.
Usage Basics
INN And Brand Names Available In Australia
What are the active ingredients and tablet strengths?
The INN components are levodopa, carbidopa and entacapone in a fixed triple combination.
In Australia the brand Stalevo is supplied as brown, oval film-coated tablets in blister packs.
Every Stalevo tablet contains 200 mg entacapone as a fixed amount.
- Stalevo 50
- 12.5 mg carbidopa + 50 mg levodopa + 200 mg entacapone.
- Stalevo 75
- 18.75 mg carbidopa + 75 mg levodopa + 200 mg entacapone.
- Stalevo 100
- 25 mg carbidopa + 100 mg levodopa + 200 mg entacapone.
- Stalevo 125
- 31.25 mg carbidopa + 125 mg levodopa + 200 mg entacapone.
- Stalevo 150
- 37.5 mg carbidopa + 150 mg levodopa + 200 mg entacapone.
- Stalevo 200
- 50 mg carbidopa + 200 mg levodopa + 200 mg entacapone.
Legal Classification (TGA‑Approved, PBS Context)
Stalevo is a TGA‑approved prescription-only medicine in Australia.
PBS subsidy status can change and should be checked at the point of prescribing or via pharmacy systems.
Required documents for dispensing:
- Valid prescription from an authorised prescriber.
- PBS concession card if subsidised under the PBS.
- Proof of identity where required for certain authority prescriptions.
Dosing Guide
Standard Regimens (PBS Reference Dosing)
How is Stalevo started and continued?
Initiation is matched to the patient’s current levodopa/DDCI regimen by converting to the closest Stalevo tablet strength.
Typical maintenance is one tablet per dose, given three to seven times daily and adjusted to control motor symptoms.
Do not exceed 200 mg levodopa per dose in Stalevo formulations.
The daily maximum guided by product summaries is approximately 2,000 mg levodopa per day.
| Current Levodopa/DDCI Regimen | Nearest Stalevo Tablet Strength |
|---|---|
| Levodopa 100 mg + Carbidopa 25 mg | Stalevo 100 (100 mg levodopa + 25 mg carbidopa + 200 mg entacapone) |
| Levodopa 200 mg + Carbidopa 50 mg | Stalevo 200 (200 mg levodopa + 50 mg carbidopa + 200 mg entacapone) |
| Levodopa 50 mg + Carbidopa 12.5 mg | Stalevo 50 (50 mg levodopa + 12.5 mg carbidopa + 200 mg entacapone) |
| Levodopa 150 mg + Carbidopa 37.5 mg | Stalevo 150 (150 mg levodopa + 37.5 mg carbidopa + 200 mg entacapone) |
Adjustments For Comorbidities
Start at lower doses for elderly patients and monitor tolerability.
Use caution and close monitoring in renal impairment.
Avoid or reduce dosing in significant hepatic impairment because entacapone exposure increases.
Consider specialist review for patients with severe cardiac disease or a history of psychosis before making major dose changes.
Q&A — “What If I Miss A Dose?”
Take the missed dose as soon as you remember unless it is close to the time for your next scheduled dose.
Do not double the next dose to make up for a missed one.
If vomiting prevents absorption or an overdose is suspected, seek emergency care immediately.
Overdose symptoms can include severe dyskinesia, confusion and arrhythmia; these need urgent medical assessment and supportive therapy.
Keep a regular dosing schedule to reduce fluctuation in symptom control.
Interaction Chart
Food And Drinks (Alcohol, Caffeine, Australian Diet Context)
How does food affect Stalevo?
High-protein meals can reduce levodopa absorption and may worsen “on” times for some patients.
Advise separating large protein-rich meals from dosing when practical to improve absorption.
Limit alcohol intake as it may exacerbate central nervous system side effects like drowsiness and dizziness.
Caffeine may change tremor perception and sleep patterns, so counsel patients about timing of coffee and energy drinks.
- Take Stalevo with a light carbohydrate snack if nausea occurs but avoid large protein-heavy meals near dosing.
- Stay well hydrated, particularly in hot Australian climates where orthostatic hypotension is a risk.
- Advise consistent meal patterns to help stabilise levodopa absorption.
Common Drug Conflicts
Stalevo interacts with several drug classes and requires review of concomitant medicines.
Non-selective MAO inhibitors are contraindicated with levodopa combinations.
Certain antipsychotics with dopamine antagonism can reduce Stalevo effectiveness.
Adrenergic agents and sympathomimetics may interact and require monitoring.
Antiemetics that block dopamine (for example, certain older agents) may counteract levodopa effects.
Combining with antihypertensives can increase the risk of hypotension.
| Interacting Drug Class | Clinical Effect | Management |
|---|---|---|
| Non-selective MAO Inhibitors | Severe hypertensive reactions | Contraindicated; avoid co-prescribing |
| Dopamine Antagonist Antipsychotics | Reduced motor benefit | Review need for antipsychotic; consider alternatives |
| Antihypertensives | Increased orthostatic hypotension risk | Monitor blood pressure, adjust doses if needed |
| Adrenergic/Sympathomimetics | Possible blood pressure changes | Monitor cardiovascular status |
User Reports & Trends (Australian Patient Voice)
What do Australian patients say about Stalevo?
Across Australian forums and review sites, common themes include improved ‘on’ time when switched from levodopa/DDCI to levodopa/carbidopa/entacapone combinations.
Some patients report an increase in dyskinesia after adding entacapone.
Sleep disturbances and urine discolouration are commonly mentioned but often described as manageable or expected.
| Reported Issue | Relative Frequency (Patient Reports) |
|---|---|
| Nausea | Common |
| Dizziness | Common |
| Dyskinesia | Common to Frequent |
| Urine Discolouration | Common |
- Pharmacists should probe effectiveness of current therapy and timing of ‘on/off’ periods.
- Ask about the severity and timing of dyskinesia and any sleepiness or hallucinations.
- Check medication burden and affordability concerns, particularly in rural areas.
Urban patients tend to report easier access and quicker pharmacy replacement, while rural patients commonly report cost and supply delays.
Access & Purchase Options (Australia)
National Chains (Chemist Warehouse, Priceline, TerryWhite Chemmart)
Stalevo is prescription-only and available through major Australian pharmacy chains and independent community pharmacies.
Price sensitivity is high and patients often compare out-of-pocket cost between large chains and local pharmacies.
- Checklist for patient support: confirm PBS eligibility before dispensing.
- Checklist for patient support: check concession card status for subsidy.
- Checklist for patient support: verify branded versus generic availability and local stock levels.
Online Pharmacies And Telehealth E‑Prescriptions
Electronic prescriptions from telehealth consultations are accepted by Australian pharmacies and can be dispensed from digital scripts.
Online and mail-order pharmacies can supply Stalevo where legal and will dispatch in original packaging with expiry checks.
Rural delivery timelines may be longer and Stalevo does not require cold-chain transport.
| Pharmacy Option | Typical Turnaround | Likely Out-Of-Pocket Cost |
|---|---|---|
| National Chain (in-store) | Same day to 2 days | Moderate; compare prices |
| Independent Community Pharmacy | Same day to 3 days | Variable; may be higher or lower |
| Online Pharmacy / Mail Order | 3–14 days (urban), 9–21 days (rural) | Moderate; shipping may apply |
Our online pharmacy can arrange discreet delivery to Australia in 9–21 days with a valid prescription.
Mechanism & Pharmacology
Simplified Explanation For Patients
How does Stalevo work?
Levodopa is a precursor that converts to dopamine in the brain to relieve motor symptoms of Parkinson’s disease.
Carbidopa prevents early breakdown of levodopa outside the brain, improving available levodopa for the brain and reducing peripheral side effects like nausea.
Entacapone blocks the peripheral COMT enzyme, prolonging levodopa effect and reducing “off” time.
- Levodopa
- Dopamine precursor that restores brain dopamine levels.
- Carbidopa
- A DDC inhibitor that reduces peripheral levodopa metabolism.
- Entacapone
- A COMT inhibitor that extends levodopa duration of action.
Clinical Terms
The ATC code for levodopa combinations is N04BA03, useful for clinicians and electronic records.
In Stalevo formulations, entacapone is fixed at 200 mg per tablet across all strengths.
A visual infographic showing levodopa conversion to dopamine, carbidopa blocking peripheral DDC and entacapone blocking peripheral COMT is useful for patient education.
Indications & Off‑Label Uses
Approved Indications By TGA
Stalevo is indicated for the treatment of Parkinson’s disease in adults experiencing motor fluctuations (“wearing‑off”) despite standard levodopa/DDCI therapy.
It is prescribed only for adults and not established as safe in those under 18 years.
Off‑Label Uses In Australian Clinical Practice
Off‑label use of Stalevo is uncommon.
Neurologists may consider tailored adjustments for complex motor fluctuations or in combination with other Parkinson’s disease agents under specialist supervision.
- Contraindications and cautions to consider for off‑label use include psychosis.
- Contraindications and cautions to consider for off‑label use include severe cardiac disease.
- Contraindications and cautions to consider for off‑label use include significant hepatic impairment.
Key Clinical Findings (Australia & International)
What does the evidence say about adding entacapone?
Randomised trials and meta-analyses show that entacapone added to levodopa/DDCI reduces daily “off” time and increases “on” time in patients with motor fluctuations.
Combined levodopa/carbidopa/entacapone tablets streamline dosing and may improve adherence compared to taking separate agents.
Symptomatic benefits are balanced against an increased risk of dyskinesia; monitor and titrate doses accordingly.
| Outcome | Finding |
|---|---|
| Off Time Reduction | Entacapone reduces daily off time in patients with motor fluctuations. |
| Common Adverse Effects | Dyskinesia, nausea, dizziness, urine discolouration. |
| Regulatory Approvals | FDA (2003), EMA (2005), TGA national approvals for Rx-only use. |
Editors drafting clinical summaries should include trial names, year, sample size and endpoints when referencing primary literature.
Alternatives Matrix
PBS‑Listed Alternatives Comparison Table
| Product | Active Ingredients | Dosing Convenience | PBS Status | Common Side Effects | Cost Implications |
|---|---|---|---|---|---|
| Sinemet | Levodopa/Carbidopa | Multiple strengths; flexible titration | PBS-listed (check schedule) | Nausea, dizziness, dyskinesia | Often lower cost than combinations depending on subsidy |
| Madopar | Levodopa/Benserazide | Alternative DDC inhibitor | PBS-listed (check schedule) | Gastrointestinal upset, dyskinesia | Variable; check PBS |
| Comtan | Entacapone (monotherapy adjunct) | Added to levodopa/DDCI separately | PBS-listed (check schedule) | Diarrhoea, urine discolouration | Additional drug cost if not combined |
Pros And Cons Checklist
- Pros of Stalevo: single-tablet combination, fixed entacapone 200 mg, may reduce off time and simplify dosing.
- Cons of Stalevo: fixed entacapone dose limits fine titration, potential for increased dyskinesia, out-of-pocket cost concerns.
- Clinician checklist when considering switching: symptom profile, current levodopa dosing, renal and hepatic function, psychiatric history, patient preference.
Common Questions (Australian Pharmacy Consultations)
Patients often ask short practical questions at the pharmacy.
- Will it change my movement side effects? — Expect improved on time, but dyskinesia may increase; report new involuntary movements.
- Why is my urine brown? — Brownish urine is a known effect of entacapone and typically harmless, but report any other concerning symptoms.
- How soon will I feel better? — Adjustments vary; some patients notice changes within days, while full benefit depends on dose titration.
- Can I stop other Parkinson’s meds? — Do not stop other medications without prescriber advice; changes should be supervised.
- Pharmacist prompts: check adherence and timing of doses.
- Pharmacist prompts: note onset and duration of on periods and severity of dyskinesia.
- Pharmacist prompts: screen for orthostatic symptoms and daytime sleepiness.
Include micro-FAQ snippets on pharmacy leaflets covering missed dose, driving, pregnancy and storage advice.
Price & Access Comparison Table
Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Requirement
| Pharmacy Type | Likely Wait Time | PBS Subsidy | Typical OOP Range (Estimate) | Notes |
|---|---|---|---|---|
| Chain Pharmacy (In-Store) | Same day to 2 days | Check PBS at dispensing | Moderate; varies by concession | Convenient repeats; price comparisons common |
| Independent Pharmacy | Same day to 3 days | Check PBS at dispensing | Variable | Local service and clinical continuity |
| Online Pharmacy / Mail Order | 3–14 days urban; 9–21 days rural | Check PBS; digital scripts accepted | Moderate; shipping may apply | Good for repeat supplies and remote patients |
Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability
- Confirm PBS eligibility and concession card details.
- Request repeat authorisations where required to avoid gaps in supply.
- Consider mail order for rural patients and check expected delivery times.
- Check stock before travel and carry a copy of the prescription or digital script.
Registration & Regulation
TGA Approval
Stalevo is approved by the TGA as a prescription-only medicine.
Novartis and Orion are the developers/manufacturers associated with Stalevo registrations in multiple markets.
Record INN and ATC code N04BA03 in clinical systems for accuracy.
PBS Subsidy Details
PBS listing and authority requirements can vary by formulation and over time.
Pharmacists should verify the current PBS schedule and authority rules at the time of dispensing.
- Regulatory checks: verify TGA ARTG number where needed.
- Regulatory checks: confirm PBS item code and any authority forms.
- Regulatory checks: note sponsor or distributor details for supply queries.
Storage & Handling (Household + Pharmacy)
Household Storage In Australian Climate (Heat/Humidity)
Store Stalevo below 30°C and protect from moisture and light.
Advise patients to avoid storing tablets in bathrooms or car gloveboxes in hot and humid Australian conditions.
Keep tablets in their original blister pack until use to preserve stability.
Cold‑Chain Handling For Pharmacies
No cold chain is required for Stalevo.
Pharmacies should control ambient temperature, rotate stock and inspect blister integrity during transport, especially for remote deliveries.
- Dispensing checklist: confirm expiry date and intact blister packs.
- Dispensing checklist: counsel patients on household storage and what to do with leftover tablets.
Guidelines For Proper Use (Pharmacist Counselling & Patient Steps)
Australian Pharmacist Counselling Style
Begin counselling by stating the treatment goal: reduce ‘off’ time and improve mobility.
Explain the dosing schedule clearly and discuss expected benefits and timelines.
List common side effects such as nausea, dizziness, dyskinesia and urine discolouration and explain when to seek help.
Provide written instructions and a dosing conversion table for patients and carers.
- Patient checklist: confirm exact tablet strength and timing with meals.
- Patient checklist: watch for signs of hypotension, hallucinations or severe dyskinesia.
- Patient checklist: describe safe storage and emergency steps for overdose.
Patient Advice From PBS And National Health Authorities
Do not stop Stalevo abruptly without medical advice as abrupt withdrawal can worsen symptoms.
Missed dose guidance: take as soon as possible but do not double up doses.
In suspected overdose, seek emergency care; overdose symptoms can include dyskinesia, confusion and arrhythmia.
Arrange periodic medication reviews and consider referral to a neurologist or movement disorder clinic when motor fluctuations change.
Provide or suggest downloadable checklists and dosing conversion tables for carers to reduce medication errors.
Delivery Across Australia
| City | Region | Delivery time |
|---|---|---|
| Sydney | New South Wales | 9–14 days |
| Melbourne | Victoria | 9–14 days |
| Brisbane | Queensland | 9–14 days |
| Perth | Western Australia | 9–14 days |
| Adelaide | South Australia | 9–14 days |
| Hobart | Tasmania | 9–14 days |
| Canberra | Australian Capital Territory | 9–14 days |
| Gold Coast | Queensland | 9–14 days |
| Newcastle | New South Wales | 9–14 days |
| Wollongong | New South Wales | 14–21 days |
| Townsville | Queensland | 14–21 days |
| Darwin | Northern Territory | 14–21 days |
| Bendigo | Victoria | 14–21 days |
| Launceston | Tasmania | 14–21 days |